Investment View: Vodafone and GSK – my twin choices for an equitable return

Vodafone. Price: 170p. OUR VIEW: Buy
GlaxoSmithKline. PRICE: 1,427.5p OUR VIEW: Buy

Can equity markets remain at their current levels or is there another nasty squall bubbling on the horizon?

Well, if you put 10 professionals in a room together you would almost certainly get 10 different answers.

The main word on everyone's lips at the moment is "uncertainty". Nobody is really sure what nasties might be peeping over the horizon. And equities could easily take a bath if any of those nasties jumps up, just as one did in August last year.

The most obvious shocks are likely to come from Europe, where the next crisis in the sovereign debt of a fringe country (Spain?) looks like it is just waiting to break out. But don't forget the US, which has debt problems of its own, not helped by a bitterly partisan Congress and a presidential election. And don't forget China. On Friday, its GDP growth came in at the low end of where it has been historically. Time to bite those fingernails?

Maybe not just yet. Balanced against that, there have been at least some signs of economic improvement in places, but if things are actually getting better, people don't want to risk saying so just yet. What should sustain share prices at their current levels is monetary policy across Europe and the US. Rock-bottom interest rates mean you get nothing for holding cash. Bond yields are also pitiful, at least on those you might want to hold (eg German bunds, or perhaps gilts).

In other words, if you want any sort of return, equities are just about the only asset class that can provide it. The numbers tell their own story: the FTSE 100 currently yields just under 4 per cent, against a 10-year gilt offering just over 2 per cent.

All the same, against this background a safety-first strategy is no bad thing. Bill Dinning, the head of strategy and economics at Kames Capital, sums it up nicely: "Companies with high dividend yields and good prospects of increasing those dividends are attractive."

Here are two that I like, both of which fit the bill.

First up is Vodafone. The shares have basically been treading water for the past six months. However, they have much to recommend them. Whatever happens to the global economy people are not going to stop using their mobile phones.

Strategically Vodafone has been doing the right things. It has been cutting down on the number of small stakes it has all over the place, sensibly rationalising its portfolio. The dividend from its US joint venture is being shared out among investors. It has been very actively buying back shares in recent weeks. Then there is the impressive, and growing, dividend yield. Vodafone offers a forecast payout of 7.4 per cent for the year to the end of March 2012, 7.6 per cent for the current trading year.

The business is highly cash generative (so the yield isn't under much threat) and ought to be able to start growing earnings per share next year.

This column is unique among investment views in at least taking note of ethical issues, and Vodafone's tax affairs have been attracting a fair amount of comment recently. Let's be clear about this: if the company deserves a kicking for paying a pittance, then so does HM Revenue & Customs for allowing this. I suspect the group will ultimately have to dig into its pockets to keep everyone happy.

That needs to be borne in mind, but Vodafone still trades on a relatively benign forecast multiple of 10.8 times this year's earnings. Unlike the cigarette companies I looked at last week, Vodafone does hold a place in the FTSE4Good index, so it at least meets various corporate and social responsibility standards (take your own view on how good those standards are).

As does GlaxoSmithKline (GSK), the drugs group which is my second safety-first pick. Its yield is not quite as spectacular, forecast at 5.2 per cent for this year and 5.6 per cent next year, but earnings per share growth is better (7 per cent this year followed by 9 per cent). At the same time, its multiple is by no means stretched at 11.6 times forecast 2012 earnings, falling to 10.7 times in 2013.

GSK's product is even more resistant to a fresh downturn than Vodafone's (people don't stop getting sick in a recession, au contraire) and the company looks to be in fair health.

Drugs companies, it is true, aren't finding life easy right now. New treatments are proving hard, and expensive, to develop.

GSK does at least have the resources to gobble up any promising biotech it should want, and is taking advantage of government measures to make research cheaper from a taxation standpoint (if you develop and patent new treatments in the UK you pay tax at just 10 per cent on the earnings).

Again, GSK is a good, safety-first buy whose yield alone should keep investors happy even if share prices generally prove to be choppy.

News
Russia Today’s new UK channel began broadcasting yesterday. Discussions so far have included why Britons see Russia as ‘the bad guy’
tv

New UK station Russia Today gives a very bizarre view of Britain

Voices
Left: An illustration of the original Jim Crowe, played by TD Rice Right: A Couple dressed as Ray and Janay Rice
voices

By performing as African Americans or Indians, white people get to play act a kind of 'imaginary liberation', writes Michael Mark Cohen

News
John Moore inspired this Coca Cola Christmas advert
people

News
people

Top Gear presenter is no stranger to foot-in-mouth controversy

PROMOTED VIDEO
News
ebooksAn unforgettable anthology of contemporary reportage
Life and Style
Jamie Oliver’s version of Jollof rice led thousands of people to post angry comments on his website
food + drink
Arts and Entertainment
Vividly drawn: Timothy Spall in Mike Leigh’s ‘Mr Turner’
film

Review: Mike Leigh's biopic is a rambling, rich character study

Arts and Entertainment
glastonbury
Arts and Entertainment
Shelley Duvall stars in Stanley Kubrick's The Shining
film
Arts and Entertainment
Shock of the news: Jake Gyllenhaal in ‘Nightcrawler’
film
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

The benefits of Recruitment at SThree...

£18000 - £23000 per annum + Comission: SThree: SThree, International Recruitme...

Trainee Recruitment Consultants

£20000 - £25000 per annum + OTE £35K: SThree: We consistently strive to be the...

Finance Assistant - Part time - 9 month FTC

£20000 - £23250 Per Annum pro rata: Clearwater People Solutions Ltd: Pro rata ...

Marketing Manager

£40 - 48k + Benefits: Guru Careers: We are seeking a Marketing Manager to join...

Day In a Page

The drugs revolution starts now as MPs agree its high time for change

The drugs revolution starts now as MPs agree its high time for change

Commons debate highlights growing cross-party consensus on softening UK drugs legislation, unchanged for 43 years
The camera is turned on tabloid editors in Richard Peppiatt's 'One Rogue Reporter'

Gotcha! The camera is turned on tabloid editors

Hugh Grant says Richard Peppiatt's 'One Rogue Reporter' documentary will highlight issues raised by Leveson
Fall of the Berlin Wall: It was thanks to Mikhail Gorbachev that this symbol of division fell

Fall of the Berlin Wall

It was thanks to Gorbachev that this symbol of division fell
Halloween 2014: What makes Ouija boards, demon dolls, and evil clowns so frightening?

What makes ouija boards and demon dolls scary?

Ouija boards, demon dolls, evil children and clowns are all classic tropes of horror, and this year’s Halloween releases feature them all. What makes them so frightening, decade after decade?
A safari in modern Britain: Rose Rouse reveals how her four-year tour of Harlesden taught her as much about the UK as it did about NW10

Rose Rouse's safari in modern Britain

Rouse decided to walk and talk with as many different people as possible in her neighbourhood of Harlesden and her experiences have been published in a new book
Welcome to my world of no smell and odd tastes: How a bike accident left one woman living with unwanted food mash-ups

'My world of no smell and odd tastes'

A head injury from a bicycle accident had the surprising effect of robbing Nell Frizzell of two of her senses

Matt Parker is proud of his square roots

The "stand-up mathematician" is using comedy nights to preach maths to big audiences
Paul Scholes column: Beating Manchester City is vital part of life at Manchester United. This is first major test for Luke Shaw, Angel Di Maria and Radamel Falcao – it’s not a game to lose

Paul Scholes column

Beating City is vital part of life at United. This is first major test for Shaw, Di Maria and Falcao – it’s not a game to lose
Frank Warren: Call me an old git, but I just can't see that there's a place for women’s boxing

Frank Warren column

Call me an old git, but I just can't see that there's a place for women’s boxing
Adrian Heath interview: Former Everton striker prepares his Orlando City side for the MLS - and having Kaka in the dressing room

Adrian Heath's American dream...

Former Everton striker prepares his Orlando City side for the MLS - and having Kaka in the dressing room
Simon Hart: Manchester City will rise again but they need to change their attitude

Manchester City will rise again but they need to change their attitude

Manuel Pellegrini’s side are too good to fail and derby allows them to start again, says Simon Hart
Isis in Syria: A general reveals the lack of communication with the US - and his country's awkward relationship with their allies-by-default

A Syrian general speaks

A senior officer of Bashar al-Assad’s regime talks to Robert Fisk about his army’s brutal struggle with Isis, in a dirty war whose challenges include widespread atrocities
‘A bit of a shock...’ Cambridge economist with Glasgow roots becomes Zambia’s acting President

‘A bit of a shock...’ Economist with Glasgow roots becomes Zambia’s acting President

Guy Scott's predecessor, Michael Sata, died in a London hospital this week after a lengthy illness
Fall of the Berlin Wall: History catches up with Erich Honecker - the East German leader who praised the Iron Curtain and claimed it prevented a Third World War

Fall of the Berlin Wall

History catches up with Erich Honecker - the East German leader who praised the Iron Curtain and claimed it prevented a Third World War
How to turn your mobile phone into easy money

Turn your mobile phone into easy money

There are 90 million unused mobiles in the UK, which would be worth £7bn if we cashed them in, says David Crookes